Pre-clinical evaluation of a new antimicrobial enzyme for the control of wound bioburden

Wounds

Volumn 21, Issue 3, 2009, Pages 65-73

  De Smet, Kris ^a   Van Den Plas, Dave ^a   Lens, Dimitri ^a   Sollie, Philippe ^a  

^a Flen Pharma NV ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67249164829     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins, and histatins. Biotechnol Lett. 2005;27(18):1337-1347.
2. Mangoni ML, Marcellini HG, Simmaco M. Biological characterization and modes of action of temporins and bombinins H, multiple forms of short and mildly cationic anti-microbial peptides from amphibian skin. J Pept Sci. 2007;13(9):603-613.
3. Wong JH, Xia L, Ng TB. A review of defensins of diverse origins. Curr Protein Pept Sci. 2007;8(5):446-459.
4. Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24(12):1551-1557.
5. Miller RA, Britigan BE. Role of oxidants in microbial pathophysiology. Clin Microbiol Rev. 1997;10(1):1-18.
6. Gardner JF, Peel MM. Introduction to Sterilization and Disinfection. London, UK: Churchill Livingstone; 1986.
7. Iyer GYN, Islam DMF, Quastel JH. Biochemical aspects of phagocytosis. Nature. 1961;192:535-541.
8. Klebanoff SJ, Clark RA. The Neutrophil: Function and Clinical Disorders. Amsterdam: North-Holland Publishing Co; 1978.
9. Bass DA, Szejda P. Mechanisms of killing of newborn larvae of Trichinella spiralis by neutrophils and eosinophils. Killing by generators of hydrogen peroxide in vitro. J Clin Invest. 1979;64(6):1558-1564.
10. Rager-Zisman B, Kunkel M.Tanaka Y, Bloom BR. Role of macrophage oxidative metabolism in resistance to vesicular stomatitis virus infection. Infect Immun. 1982;36(3): 1229-1237.
11. Thomas EL, Milligan TW, Joyner RE, Jefferson MM. Antibacterial activity of hydrogen peroxide and the lac-toperoxidase-hydrogen peroxide-thiocyanate system against oral streptococci. Infect Immun. 1994;62(2):529-535.
12. Cina SJ, Downs JC, Conradi SE. Hydrogen peroxide: a source of lethal oxygen embolism. Case report and review of the literature. Am J Forensic Med Pathol. 1994;15(l):44-50.
13. Henley N, Carlson DA, Kaehr DM, Clements B. Air embolism associated with irrigation of external fixator pin sites with hydrogen peroxide.A report of two cases. J Bone Joint Surg Am. 2004;86-A(4):821-822.
14. Jones PM, Segal SH, Gelb AW. Venous oxygen embolism produced by injection of hydrogen peroxide into an enterocutaneous fistula. Anesth Analg. 2004;99(6):186l-1863.
15. Prabhakar H, Rath GP.Venous oxygen embolism with use of hydrogen peroxide during craniotomy in the supine position.J Clin Neurosci. 2008; 15(9): 1072.
16. Prabhakar H, Rath GP, Arora R, Jha M. Increased risk of venous oxygen embolism with the use of hydrogen peroxide in sitting position. J Clin Anesth. 2007;19(5):406-407.
17. Watt BE, Proudfoot AT, Vale JA. Hydrogen peroxide poisoning. Toxicol Rev. 2004;23(l):51-57.
18. Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis. 2002;8(l):23-29.
19. Bosch EH, van Doorne H, de Vries S.The lactoperoxidase system: the influence of iodide and the chemical and antimicrobial stability over the period of about 18 months. J Appl Microbiol. 2000;89(2):215-224.
20. Majerus PM, Courtois PA. Susceptibility of Candida albicans to peroxidase-catalyzed oxidation products of thio-cyanate, iodide and bromide. J Biol Buccale. 1992;20(4):241-245.
21. Ihalin R, Loimaranta V, Lenander-Lumikari M, Tenovuo J. The sensitivity of Porphyromonas gingivalis and Fusobacterium nucleatum to different (pseudo)halide-peroxidase combinations compared with mutans streptococci. J Med Microbiol. 2001;50(l):42-48.
22. Ihalin R, Loimaranta V, Lenander-Lumikari M, Tenovuo J. The effects of different (pseudo) halide substrates on peroxidase-mediated killing of Actinobacillus actino-mycetemcomitans. J Periodontal Res. 1998;33(7):421-427.
23. Van Den Plas D, De Smet K, Sollie P, inventors; Flen Pharma, assignee. Improved antimicrobial peroxidase compositions. EP1893187. November 2008.
24. Gallant-Behm CL, Yin HQ, Liu S, et al. Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Repair Regen. 2005;13(4):412-421.
25. Van Den Plas D, De Smet K, Lens D, Sollie R Differential cell death programmes induced by silver dressings in vitro. Eur J Dermatol. 2008;l8(4):4l6-42l.
26. de la Brassinne M.Thirion L, Horvat LI.A novel method of comparing the healing properties of two hydrogels in chronic leg ulcers. J Eur Acad Dermatol Venereol. 2006;20(2):131-135.
27. Vandenbulcke K, Horvat LI, De Mil M, Siegers G, Beele H. Evaluation of the antibacterial activity and toxicity of 2 new hydrogels: a pilot study. Int J Low Extrem Wounds. 2006; 5(2): 109-114.
28. Ovington LG. Advances in wound dressings. Clin Dermatol. 2007;25(l):33-38.
29. Schultz GS, Barillo DJ, Mozingo DW, Chin GA; Wound Bed Advisory Board Members. Wound bed preparation and a brief history of TIME. Int Wound J. 2004;l(l):19-32.
30. Lacarrubba F, Patania L, Micali G. Open-label evaluation of an alginate hydrogel in the treatment of leg ulcers. Ital J Dermatol Venerol. 2005; 140(l):83-88.